Lung for Life

Lung Cancer is by far the leading cause of all cancer deaths in men and women. Smokers have a 20 times higher risk of getting Lung Cancer and up to 1 in 10 smokers will develop Cancer.

The Tumour can grow undetected for years before it can be seen on a conventional Chest X-ray or cause symptoms. Lung Cancers are therefore typically large and at an advanced stage by the time they are diagnosed. The prognosis is then very poor, with an average 5 year survival rate of 15%. Conversely, if Lung cancer is detected in its earliest stage, a 5 year survival rate higher than 80% is attainable.

The Lung For Life Scan is the most sensitive and accurate method available for detecting the earliest Lung Cancers. The majority of early stage Cancers found with this technology can be removed and cured.

Low dose Lung CT Scan

The Low dose Lung CT Scan is the most sensitive test available for the detection of the earliest Lung Tumours and Cancers – a few millimetres in size (smaller than a grain of rice).

It is also useful in detecting many other early lung abnormalities, such as Emphysaema and Chronic Bronchitis, many years before they are evident on a Chest X-ray.

In addition, the Scan accurately diagnoses other serious chest abnormalities such as other Tumours, abnormal Lymph Glands, Aneurysms etc.

The scan is non-invasive, safe, rapid and painless. The entire process takes less than 15 minutes.

It iis performed with ultra low-dose parameters to limit X-ray dose to the absolute minimum.

Preparation for the Scan:

None.

Requirements for the Scan:

None. It does not require contrast (“dye”) or even an IV line (needle).

Lung cancer will account for about 13% of all new cancers.

The chance that a man will develop Lung Cancer is 1 in 13 and for a woman, it is 1 in 18 (this figure includes all people and doesn’t take into account whether or not they smoke).

More people die of Lung Cancer than of Colon, Breast, and Prostate cancers combined.

Lung Cancer is the leading cause of cancer deaths in men, accounting for 32% of Cancer mortality and the leading cause of cancer deaths in women, accounting for 25%of Cancer mortality.

Nearly 60% of people diagnosed with lung cancer die within one year of their diagnosis. Nearly 75% die within 2 years.

The 5-year relative survival rate for all stages of lung cancer is 15%. For people whose lung cancer is found and treated before it has spread to lymph nodes or other organs, the average 5-year relative survival rate is about 49%. However, only 16% of people with lung cancer are diagnosed at this early stage. The Stage IV (spread to distant sites) five year survival rate is only 2%.

There has been a significant increase in specific cancer mortality since 1950.

Source: The American Cancer Society

https://www.lungcancerscreeningguide.org

Who should consider the Lung for Life Scans?

The Scan should be considered:

  • Smokers from 50 – 55 years of age with a significant tobacco history (20-30 pack years).
  • Non-smokers with previous significant smoking history (above) who have stopped smoking within 15 years.
  • Family History of Lung Cancer.
  • Exposure to cancer-causing agents in the workplace or environment, such as asbestos.
  • Chronic lung diseases, particularly C.O.P.D. (Chronic Obstructive Pulmonary Disease) – Emphysaema and Chronic Bronchitis.
  • History of unexplained or recurrent pneumonias.
Who should consider the Lung for Life Scans?

How often must the Lung For Life Scans be performed?

It should be repeated annually for three years.